OtoSCOPE® Genetic Hearing Loss Testing

The BEST comprehensive test for genetic forms of hearing loss including non-syndromic hearing loss, non-syndromic mimics (such as Usher Syndrome, Deafness-Infertility Syndrome, Perrault Syndrome and Pendred syndrome, among others) and common forms of syndromic hearing loss.  In the Molecular Otolaryngology & Renal Research Laboratories (MORL), we continue to refine our diagnostic menu to provide the best testing options for your patients with hearing loss.

What is in OtoSCOPE® v9?

Why OtoSCOPE® and the MORL?  Simple – get the best.

  • Detailed, case-by-case review
    • Every patient’s clinical history, hearing loss phenotype, and family history are discussed with our multidisciplinary Hearing Group
  • Expertise and experience
  • Commitment to advancing understanding of hearing and deafness
    • Exploration of variants of uncertain significance through our HEAR VUS Program provides familial testing free of charge for qualifying families
    • Innovative research in basic science, bioinformatics, and translational studies advances our understanding of hearing and deafness and improves clinical care
    • Multiple publications highlight our contributions to the field and are widely available to the scientific community and general public

Next generation sequencing with read depth analysis for CNV detection.

Turnaround time: 
Turnaround time is approximately 6 weeks.

Sample Required:
8 - 10 cc. whole blood in lavender (EDTA) top tubes OR 10 μg DNA, minimum concentration: 50 ng/μl (A260/A280 1.8-2) resuspended in 0.1mM EDTA (10mM Tris HC1, 0.1mM EDTA, pH 8, Teknova Cat#T0220).

Cost & CPT Codes 

Other Web Sites:

The Clinical Diagnostics Service of the Molecular Otolaryngology and Renal Research Laboratories is a Joint Commission-approved CLIA-accredited diagnostic laboratory.